Is sitagliptin effective for the treatment of COVID-19?
Eur J Hosp Pharm
.
2022 Nov;29(6):e6.
doi: 10.1136/ejhpharm-2021-002702.
Epub 2021 Jan 27.
Authors
Hasan Memiş
1
,
Ahmet Çakır
1
,
Mefküre Durmuş
1
,
Selim Gök
1
,
Ömer Faruk Bahçeciȯğlu
2
Affiliations
1
Clinical Pharmacy, Inonu University, Malatya, Turkey.
2
Clinical Pharmacy, Inonu University, Malatya, Turkey
[email protected]
.
PMID:
33504509
PMCID:
PMC9614154
DOI:
10.1136/ejhpharm-2021-002702
No abstract available
Keywords:
COVID-19; clinical medicine; drug monitoring; drug substitution; evidence-based medicine.
Publication types
Letter
MeSH terms
COVID-19 Drug Treatment*
Humans
Sitagliptin Phosphate* / therapeutic use
Substances
Sitagliptin Phosphate